Beam Therapeutics (BEAM) Shares Outstanding (2019 - 2026)

Beam Therapeutics (BEAM) has 8 years of Shares Outstanding data on file, last reported at $102.7 million in Q1 2026.

• Quarterly Shares Outstanding rose 2.17% year-over-year to $102.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $102.7 million (up 2.17% YoY) and the FY2025 annual result came in at $101.7 million, up 21.66% from the prior year.
• Shares Outstanding rose to $102.7 million in Q1 2026 per BEAM's latest filing, from $101.7 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $102.7 million in Q1 2026 and bottomed at $69.8 million in Q1 2022.
• The 5-year median for Shares Outstanding is $82.3 million (2024), against an average of $84.3 million.
• The widest annual swing landed in 2025, when Shares Outstanding advanced 22.77%; it then advanced 2.17% in 2026.
• Tracing BEAM's Shares Outstanding over 5 years: stood at $71.3 million in 2022, then rose by 14.53% to $81.6 million in 2023, then increased by 2.45% to $83.6 million in 2024, then gained by 21.66% to $101.7 million in 2025, then climbed by 0.98% to $102.7 million in 2026.
• Per Business Quant, the three latest BEAM Shares Outstanding figures stand at $102.7 million (Q1 2026), $101.7 million (Q4 2025), and $101.4 million (Q3 2025).

Peer Comparison